3 completed, 2 terminated. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Terminated 2 |
Follow Recurrent Colon Cancer: new trials by email Literature Review of Recurrent Colon Cancer trials Research Report on Recurrent Colon Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy irinotecan hydrochloride, leucovorin calcium, fluorouracil - Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 3 | Terminated | National Cancer Institute (NCI) | 72 | 2007-06-01 | 2014-07-31 |
| Combination Chemotherapy and Bevacizumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Colorectal Cancer oxaliplatin, leucovorin calcium, capecitabine - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 3 | Terminated | National Cancer Institute (NCI) | 2200 | 2004-04-01 | 2013-01-25 |
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated bevacizumab, oxaliplatin, leucovorin calcium - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 3 | Completed | National Cancer Institute (NCI) | 880 | 2001-09-01 | 2013-01-24 |
| Irinotecan Compared With Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer irinotecan hydrochloride, oxaliplatin, leucovorin calcium - Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum | Phase 3 | Completed | National Cancer Institute (NCI) | 560 | 1999-11-01 | 2013-05-03 |
| Fluorouracil With or Without Eniluracil in Treating Patients With Advanced Colorectal Cancer fluorouracil, eniluracil - Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 3 | Completed | National Cancer Institute (NCI) | 950 | 1999-04-01 | 2013-01-24 |
Colonic Neoplasms (5) · Rectal Neoplasms (5)
Colonic Diseases (5) · Colorectal Neoplasms (5) · Digestive System Diseases (5) · Digestive System Neoplasms (5) · Gastrointestinal Diseases (5) · Gastrointestinal Neoplasms (5) · Intestinal Diseases (5) · Intestinal Neoplasms (5) · Neoplasms (5) · Neoplasms by Site (5) · Rectal Diseases (5)
Fluorouracil (5) · Leucovorin (4) · Bevacizumab (3) · Oxaliplatin (3) · Irinotecan (2) · Capecitabine (1) · Cetuximab (1) · eniluracil (1)
National Cancer Institute (NCI) (5)
United States (5)
Bruce Giantonio (1) · Charles Blanke (1) · Henry Pitot (1) · John Hines (1) · Philip Gold (1)
U10CA021115 (2), U10CA032102 (2), U10CA025224 (1)